Home > Boards > US OTC > Medical - Equipment > Kontrol Technologies Corp. (KNRLF)

Kontrol Receives Approval for Government Grant to Accelerate

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JohnCM Member Profile
Member Level 
Followed By 656
Posts 60,029
Boards Moderated 42
Alias Born 06/01/08
160x600 placeholder
JohnCM Member Level  Sunday, 11/01/20 01:56:30 AM
Re: None
Post # of 226 
Quote:
Kontrol Receives Approval for Government Grant to Accelerate the Development of New COVID-19 Testing Technology
- Kontrol BioCloud® --


August 5, 2020

Kontrol Energy Corp. (CSE:KNR)(OTCQB:KNRLF)(FSE:1K8) ("Kontrol" or "Company") is pleased to announce that it has received approval for an initial government grant of $50,000 from the National Research Council of Canada to accelerate its new Covid-19 testing technology, the Kontrol BioCloud® analyzer ("BioCloud analyzer" or "BioCloud").

Can we measure for COVID-19 like we do for air quality?

Drawing from its extensive industry experience in air emissions and air quality monitoring, Kontrol is developing a new technology designed to detect and alert for COVID-19, in real-time, through rapid on-site air sampling and detection of aerosol and droplet encapsulated viruses in indoor and outdoor environments.

"Our team has been working to bring BioCloud to market since the onset of COVID-19 and we see a great need for a technology which can provide a level of assurance that spaces where individuals work and congregate can be safe," says Paul Ghezzi, Chief Executive Officer of Kontrol. "If successful, BioCloud will be able to provide pro-active virus detection capabilities with an alert and notification system in public settings and to help maintain confidence as economies re-open."

COVID-19 Testing

The current focus of testing for COVID-19 has been individual swabs. While this remains an important part of the testing regime it would not be possible to test all individuals daily in the cases of large gatherings and transportation.

According to the Center for Disease Control, "the virus that causes COVID-19 is thought to spread mainly from person to person, mainly through respiratory droplets produced when an infected person coughs, sneezes, or talks. These droplets can land in the mouths or noses of people who are nearby or possibly be inhaled into the lungs. COVID-19 seems to be spreading easily and sustainably in the community ("community spread"). Community spread means people have been infected with the virus in an area, including some who are not sure how or where they became infected."

source: www.cdc.gov/coronavirus/2019-ncov/faq.html#Spread

BioCloud has been designed to operate in open spaces where crowds gather or congregate. Through constant air sampling over designated intervals of time and a propriety detection chamber, designed to interact with COVID-19, BioCloud seeks to provide a real-time detection and alert system. BioCloud's anticipated applications include schools, buildings, hospitals, transportation, or any location where crowds are gathered.

"When we initiated the design of BioCloud we leveraged our extensive experience in sampling for low level particulate matter in industrial facilities which includes air quality, emissions and various gases," says Gary Saunders, VP of Kontrol. "We appreciate the government support received to date to accelerate the development of BioCloud."

Development Plan

Kontrol has developed its initial prototype and has commenced lab testing of the detection chamber. The lab will spend the next 4 weeks testing the detection chamber and the applicable interactions with COVID-19. Following the testing period, Kontrol will announce the results and provide further details on its go-to market strategy.

Kontrol is not making any express or implied claims that its BioCloud analyzer has the ability to measure or detect COVID-19 at this time.



Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences